Search
Selected: All

Replication-defective adenovirus human type 5 recombinant as...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Restenosis/atherosclerosis diagnosis, prophylaxis and therapy

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Rhabdoviruses with reengineered coats

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Rhadino virus LANA acts in trans on a unit of rhadino virus...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Rosmarinic acid-phospholipide-complex

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Self-assembled, non-infectious, non-replicating; immunogenic ret

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Soil disinfectants and method of use

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Stabilized parenterally administrable solutions

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Stable injectable solutions of indoleacetic acid derivatives

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Storage-stable lipid vesicles and method of preparation

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Subgenomic replicons of the flavivirus dengue

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Swine vesicular disease virus expression vectors

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Synthetic whole blood and a method of making the same

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Targeting of Herpes simplex virus to specific receptors

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Temperature sensitive clustered changed-to-alanine mutants of in

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Therapeutic agent for consciousness disorder and perception and

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Transmission blocking immunogen from malaria

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Treatment for human memory impairment associated with aging

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Treatment of cancer with carcinostatic and immunostimulating age

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Trova fowl pox virus recombinants comprising heterologous insert

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.